Service public fédéral : Sécurité Sociale. - Recommandations sur l'utilisation des inhibiteurs de la pompe àprotons. INAMI. Moniteur Belge du 20/8/2010
Blume H, Donath F, Warnke A, et al. - Pharmacokinetic drug interaction profiles of proton pump inhibitors. Drug Saf, 2006, 29, 769-84. (Pubitemid 44352242)
Boparai V, Rajagopalan J, Triadafilopoulos G. - Guide to the use of proton pump inhibitors in adult patients. Drugs, 2008, 68, 925-947. (Pubitemid 351652922)
Thomson ABR, Sauve MD, Kassam N, et al. - Safety of the long-term use of proton pump inhibitors. World J Gastroenterol, 2010, 16, 2323-2330.
Abraham NS. - Prescribing proton pump inhibitor and clopidogrel together : current state of recommendations. Curr Opin Gastroenterol, 2011, 27, 558-564.
Drepper MD, Spahr L, Frossard JL. - Clopidogrel and proton pump inhibitors where do we stand in 2012? World J Gastroenterol, 2012, 18, 2161-2171.
Graham DY, Agrawal NM, Campbell DR, et al. - Ulcer prevention in long-term users of nonsteroidal antiinflammatory drugs : results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. Arch Intern Med, 2002, 162, 169-175. (Pubitemid 34098186)
Gisbert JP, Calvet X. - Review article : the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough. Aliment Pharmacol Ther, 2011, 34, 1255-1268.
Ohara T, Morishita T, Suzuki H, et al. - Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori : pathophysiologi≠cal characteristics of H. pylori-negative recurrent ulcer scars and beyond ac. Hepatogastroenterol, 2004, 51, 338-342. (Pubitemid 38445268)
Moayyedi P, Santana J, Khan M, et al. - Medical treatments in the short term management of reflux oesophagitis. Cochrane database Syst Rev, 2011, 2, CD003244.
Tack J, Fass R.- Review article : approaches to endoscopic-negative reflux disease : part of the GERD spectrum or a unique acid-related disorder? Aliment Pharmacol Ther, 2004, 19, 28-34. (Pubitemid 38253489)
Hershcovici T, Fass R. - Step-by-step management of refractory gastresophageal reflux disease. Dis Esophagus, 2013, 26, 27-36.
Niklasson A, Lindström L, Simrén M, et al. - Dyspeptic symptom development after discontinuation of a proton pump inhibitor : a double-blind placebo-controlled trial. Am J Gastroenterol, 2010, 105, 1531-1537.
Niv Y. - Gradual cessation of proton pump inhibitor (PPI) treatment may prevent rebound acid secretion, measured by the alkaline tide method, in dyspepsia and reflux patients. Med Hypotheses, 2011, 77, 451-452.
Tytgat GN, McColl K, Tack J, et al. - New algorithm for the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther, 2008, 27, 249-256.
Festi D, Scaioli E, Baldi F, et al. - Body weight, lifestyle, dietary habits and gastroesophageal reflux disease. World J Gastroenterol, 2009, 15, 1690-1701.
Nowak M, Büttner P, Harrison S, et al. - Effectiveness of lifestyle measures in the treatment of gastroesophageal reflux disease - a case series. Ther Clin Risk Manag, 2006, 2, 329-334. (Pubitemid 44349509)
Bavishi C, Dupont HL. - Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment Pharmacol Ther, 2011, 34, 1269-1281.
DuPont HL, Ericsson CD, Farthing MJG, et al. - Expert review of the evidence base for prevention of travelers' diarrhea. J Travel Med, 2009, 16, 149-160.
Vakil N. - Acid inhibition and infections outside the gastrointestinal tract. Am J Gastroenterol, 2009, 104 S17-20.
Yang Y-X, Metz DC. - Safety of proton pump inhibitor exposure. Gastroenterol, 2010, 139, 1115-1127.
Ngamruengphong S, Leontiadis GI, Radhi S, et al. - Proton pump inhibitors and risk of fracture : a systematic review and meta-analysis of observational studies. Am J Gastroenterol, 2011, 106, 1209-1218.
